Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Common Equity (2016 - 2025)

Historic Common Equity for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $438.0 million.

  • Nutex Health's Common Equity rose 44906.2% to $438.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $438.0 million, marking a year-over-year increase of 44906.2%. This contributed to the annual value of $188.5 million for FY2024, which is 13832.93% up from last year.
  • According to the latest figures from Q3 2025, Nutex Health's Common Equity is $438.0 million, which was up 44906.2% from $336.9 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Common Equity ranged from a high of $556.1 million in Q2 2022 and a low of $66.3 million during Q1 2021
  • Its 5-year average for Common Equity is $172.8 million, with a median of $109.5 million in 2023.
  • Per our database at Business Quant, Nutex Health's Common Equity soared by 1699732.36% in 2021 and then plummeted by 8053.78% in 2023.
  • Quarter analysis of 5 years shows Nutex Health's Common Equity stood at $191.6 million in 2021, then crashed by 37.19% to $120.3 million in 2022, then tumbled by 34.26% to $79.1 million in 2023, then skyrocketed by 138.33% to $188.5 million in 2024, then surged by 132.34% to $438.0 million in 2025.
  • Its Common Equity stands at $438.0 million for Q3 2025, versus $336.9 million for Q2 2025 and $255.3 million for Q1 2025.